NCT06692868 Fertility Protection for Children, Adolescents and Young Adults
| NCT ID | NCT06692868 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ulm |
| Condition | Stem Cell Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-12-09 |
| Primary Completion | 2044-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-12-09 with a primary completion date of 2044-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on improving fertility preservation and long-term care for children, adolescents, and young adults (CAYA) undergoing cancer treatments or stem cell transplantation. These treatments can harm fertility, and ensuring that patients receive the right support and follow-up care is critical. The main study goals are: 1. Understanding Fertility Risks: Researchers aim to identify factors that predict fertility problems after cancer treatments, such as the type of therapy, hormone levels, body composition, or genetic predispositions. 2. Addressing Patient and Family Needs: The program will explore the concerns, needs, and challenges faced by young patients and their parents regarding fertility. It will also examine how these issues affect their quality of life. 3. Improving Clinical Care: Current practices in fertility preservation and counseling will be studied to identify gaps and improve care structures. To achieve these goals, the program will: * Create a database to collect and analyze medical data from patients before, during, and after cancer treatments. * Study the prevalence and long-term effects of fertility problems in young patients. * Document medical interventions like fertility preservation methods (e.g., freezing eggs or sperm) and treatments for late effects. * Assess patients' and families' fertility-related quality of life and their informational needs. Ultimately, the project aims to establish an interdisciplinary center to support fertility preservation and improve the quality of care for young patients facing cancer and its treatments.
Eligibility Criteria
Children, adolescents, young adults with a diagnosis of cancer before the age of 21 years or Children, adolescents, young adults undergoing SCT for a malignant or non-malignant condition before the age of 21 years treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
Contact & Investigator
Christian Denzer, Prof. Dr.
PRINCIPAL INVESTIGATOR
Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes
Frequently Asked Questions
Who can join the NCT06692868 clinical trial?
This trial is open to participants of all sexes, studying Stem Cell Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06692868 currently recruiting?
Yes, NCT06692868 is actively recruiting participants. Contact the research team at christian.denzer@uniklinik-ulm.de for enrollment information.
Where is the NCT06692868 trial being conducted?
This trial is being conducted at Ulm, Germany.
Who is sponsoring the NCT06692868 clinical trial?
NCT06692868 is sponsored by University of Ulm. The principal investigator is Christian Denzer, Prof. Dr. at Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes. The trial plans to enroll 2,000 participants.